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Objective: To empirically test the impact of allowing respondents time to think (TTT) about their choice options on the
outcomes of a discrete choice experiments (DCE).
Methods: In total, 613 participants of the Swedish CArdioPulmonary bioImage Study (SCAPIS) completed a DCE questionnaire
that measured their preferences for receiving secondary findings of a genetic test. A Bayesian D-efficient design with 60
choice tasks divided over 4 questionnaires was used. Each choice task contained 2 scenarios with 4 attributes: type of disease,
disease penetrance probability, preventive opportunities, and effectiveness of prevention. Respondents were randomly
allocated to the TTT or no TTT (NTTT) sample. Latent class models (LCMs) were estimated to determine attribute-level values
and their relative importance. In addition, choice certainty, attribute-level interpretation, choice consistency, and potential
uptake rates were compared between samples.
Results: In the TTT sample, 92% of the respondents (245 of 267) indicated they used the TTT period to (1) read the information
they received (72%) and (2) discuss with their family (24%). In both samples, respondents were very certain about their
choices. A 3-class LCM was fitted for both samples. Preference reversals were found for 3 of the 4 attributes in one class in the
NTTT sample (34% class-membership probability). Relative importance scores of the attributes differed between the 2
samples, and significant scale effects indicating higher choice consistency in TTT sample were found.
Conclusions: Offering respondents TTT influences decision making and preferences. Developers of future DCEs regarding
complex health-related decisions are advised to consider this approach to enhance the validity of the elicited preferences.
Keywords: discrete choice experiment, hypothetical bias, stated preferences, time-to-think.
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To determine individuals’ or patients’ preferences for health-
care treatments and services, a discrete choice experiment (DCE)
can be conducted.1–3 DCEs are increasingly being used in
healthcare to inform policy makers about individuals’ or patients’
preferences and the associated welfare measures such as
willingness-to-pay or willingness-to-accept risks that can be
calculated based on those preferences.4–7 Because DCEs can be
used as input for policy making, the accuracy and validity of the
measured (ie, stated) preferences are essential.
There are 2 issues to consider, given that respondents of DCEs
are asked to choose immediately between hypothetical situations
within a highly controlled situation without any constraints (ie,
respondents do not actually have to spend their money or timess correspondence to: Jorien Veldwijk, Erasmus School of Health Policy & M
am, The Netherlands. Email: veldwijk@eshpm.eur.nl
15/$36.00 - see front matter Copyright ª 2020, ISPOR–The Professional So
doi.org/10.1016/j.jval.2020.02.014based on their choices).8 First, in the absence of any constraints,
respondents’ stated preferences are likely to differ from their
revealed preferences because they are valuing hypothetical situ-
ations and neglect or undervalue the importance of specific pro-
gram characteristics (hypothetical bias).2,9–12 For instance,
respondents often overestimate their willingness to pay for a
treatment,12–14 whereas they underestimate their willingness to
accept risks.15 Second, health- and treatment-related decisions in
real life are largely influenced by psychosocial factors such as
emotions, perceived susceptibility, and social norms,16–18 whereas
DCEs generally do not accommodate for these effects as they
solely focus on the valuation of treatment attributes.
To potentially reduce the impact of hypothetical bias and the
influence of psychosocial factors at once, a time-to-think (TTT)
approach may be used.10,19,20 In a TTT-DCE, respondents are askedanagement (ESHPM), Erasmus University Rotterdam, PO Box 1738, 3000 DR
ciety for Health Economics and Outcomes Research. Published by Elsevier Inc.
2 VALUE IN HEALTH - 2020to read all of the information in the questionnaire along with the
choice tasks, without completing it. They can complete the
questionnaire at least 1 day later. This gives them the opportunity
to think about the information they received; to deliberate about
choice options; to discuss the topic with their partner, family, or
friends; or to find/read additional information. The TTT approach
mimics real-life decision making in healthcare to a greater extent,
which is especially valuable given the complexity of treatment
decisions in healthcare DCEs.21 It is expected that allowing re-
spondents TTT will lead to more careful deliberation of the attri-
butes and discussion with their peers, thereby reducing the
influence of hypothetical bias and psychosocial factors. Therefore,
a TTT approach potentially adds to the validity of DCE outcomes.
A TTT approach has been shown to be effective in environ-
mental economics and interview-led DCE studies.10,15,22,23 Never-
theless, evidence is lacking on whether this is a workable and
valuable approach in current state-of-the-art online DCE studies
conducted in healthcare. Therefore, this study aims to empirically
test whether and to what extent the outcomes of a DCE change
when respondents are allowed TTT about their choice options.
Methods
DCE Case Study and Participant Recruitment
A DCE measuring research participants’ preferences to receive
secondary findings of a genetic test was used as a case for this
study.24 Although such decisions are considered highly compli-
cated,21,25,26 this makes it an interesting case for this study. A total
of 1300 participants of the Swedish CArdioPulmonary bioImage
Study (SCAPIS)27 were selected to receive the DCE questionnaire.
Invitations to participate were sent via postal mail and contained a
personalized link to the online survey that could be completed at
home. The SCAPIS research program is a cohort study including 30
000 Swedes aged 50 to 64 years, which aims to find risk factors to
predict cardiopulmonary disease risk levels among its partici-
pants.27 The Regional Ethical Review Board in Gothenburg
approved the study (Dnr: 610-16) in accordance with the guide-
lines laid down in the Declaration of Helsinki.
Attributes, Levels, and Choice Task Presentation
Attributes and levels were identified based on previously
published literature,28–35 4 focus group interviews with a total ofTable 1. Attributes and levels of direct choice experiment.
Attribute Level 1 Level 2
Type of the disease: Different types of diseases might have a different im
diseases and conditions.
Life threatening Physical disease
Disease penetrance: If the results from the genetic test show that you ar
probability of getting the disease can be explained by howmany people ou
affected.
5 out of every 100 30 out of every 100
Preventive opportunities: Some diseases are preventable. By taking acti
that the risk disappears, but it can decrease.
Nothing Operation
Effectiveness of the preventive measure: Different preventive measure
number of individuals who will not get the disease because of prevention
example, if 30 persons out of every 100 will get the disease and all people
will not get the disease anymore.
0% 25%16 SCAPIS research participants, and in-depth discussion with 5
experts (eg, clinical geneticists, genetic counselor). Finally, 4 at-
tributes were selected for this DCE (Table 1). A more detailed
description of the attribute selection process is described in Viberg
Johansson et al.24
Experimental Design and Pilot Testing
NGene 1.0 (ChoiceMetrics, 2011) software was used to
construct a Bayesian D-efficient design.9,36 The design of the pilot
DCE was constructed using priors indicating the direction (ie,
positive or negative) of the included attribute-level estimates. The
draft questionnaire was pilot tested among a subgroup (n = 22) of
our study population to check whether correct wording was used
and whether the target population understood the choice tasks.
Eight of these pilot tests were “think-aloud” tests, in which a
researcher was present while the participant completed the
questionnaire by reading aloud and expressing their thoughts.
Based on the pilot tests, minor changes were made throughout the
questionnaire related to layout and wording.
The final DCE design was created based on a multinomial-logit
model, including priors from the previously described pilot study.
Based on outcomes of the interviews with experts, 2-way in-
teractions between “type of the disease” with “disease penetrance
probability” and “effectiveness of the preventive measure” were
included. The final design consisted of 60 unique choice tasks,
divided over 4 blocks. Respondents were randomly assigned to 1
of these blocks.
Questionnaire
The first section of the questionnaire contained questions on
demographics and respondents’ general health status. The second
part of the questionnaire contained the choice tasks of the DCE.
Respondents received training on the attributes and levels (see
Appendix 1 in the Supplemental Materials found at https://doi.
org/10.1016/j.jval.2020.02.014) illustrated by 2 examples. Each
choice task started with the question, “Imagine that you can get
additional genetic risk information from participating in a SCAPIS
genetic test. In which situation would you prefer to receive such
information, situation 1 or situation 2?” After every choice task,
participants were asked to indicate how certain they were about
the choice they made on a 7-point Likert-type scale (ranging from
very certain to very uncertain). In the third part, health literacy37Level 3 Level 4 Level 5
pact on you. Genetic tests can be used to identify different types of
Mental disease Physical disability
e at risk of a disease, it is not certain that you will get the disease. The
t of every 100, that have the same type of gene variant as you, will be
80 out of every 100
on, you can decrease the risk of getting the disease. It does not mean
Medication Lifestyle changes
s have different abilities to reduce the risk of getting the disease. The
is calculated based on howmany got the disease in the first place. For
take the preventive measure, with an effectiveness of 50%, 15 of 30
50% 75% 90%
-- 3and numeracy38 were measured. In addition, respondents who
completed the TTT-DCE were asked if and how they had used their
TTT period. The complete survey was web based and constructed
in Sawtooth Software SSI Web 8.4.8.
Respondents were randomly assigned to either the TTT or no
TTT (NTTT) questionnaire. Respondents assigned to the NTTT
sample were asked to answer all questions of the questionnaire at
once, as is common practice in survey research. Respondents
assigned to the TTT arm were asked to complete the first part of
the questionnaire and to read all the information (including the
choice task examples) regarding the DCE. After that, respondents
were informed that their survey ended as well as that they would
be given time to consider the decisions that they were going to
make. Respondents could reenter the survey at any time, and they
were informed that they would receive a request to complete the
rest of the questionnaire after 7 days. When entering the survey
after these 7 days, respondents were offered the opportunity to
read all DCE-related material once again. All respondents who did
not start the questionnaire as well as respondents who started the
TTT part 1 but did not respond to the request to complete the rest
of the survey received 2 reminders with a 2-week interval.
Statistical Analysis
Sample descriptions
The TTT and NTTT samples are described based on mean age,
gender, educational level, health literacy and numeracy mean
score, and self-perceived general health status. By means of
independent-sample t tests and chi-square tests, differences in
these variables between the TTT and NTTT sample, between TTT
completers and TTT dropouts, and between respondents of all 4
blocks in both the TTT and NTTT sample were tested.
Dominant decision-making behavior
The proportion of respondents who always chose the alternative
with the highest penetration probability, the highest level of effec-
tiveness of the preventivemeasure, or the opt-out was calculated for
each data set. Chi-square tests were conducted to test whether this
differed significantly between the TTT and NTTT samples.
In addition, the mean number of times respondents in both
samples chose the alternative with the highest penetration
probability, the highest effectiveness of the preventive measure, or
the opt-out was calculated. Independent-sample t tests were used
to test whether the means differed significantly between the TTT
and NTTT samples.
Choice certainty
A mean certainty score was calculated for all participants.
Differences in the mean certainty score between the TTT and NTTT
sample were calculated via an independent-sample t test. In
addition, the proportion of respondents who indicated to be (very)
certain about their choices was calculated in both samples, and
differences in these proportions were estimated by means of chi-
square tests.
Attribute-level interpretation
Part-worth utilities for the 2 numerical attributes (ie, disease
penetrance probability and effectiveness of the preventive mea-
sure) were estimated to analyze whether respondents interpreted
themcorrectly on a linear scale. For that purpose, a dummyvariable
representing the highest level of the attributes was added to the
linearattributeparameter in the regressionmodel. Thedifference in
part-worth utilities between level 1 and 2 is significantly different
from the part-worth utilities between level 2 and 3 (indicating a
nonlinear attribute), if the dummy variable is significant.Attribute estimates and relative importance
Panel latent classmodels (LCMs)were estimated toadjust for the
multilevel structure of the data and to detect preference hetero-
geneity.39 In this model, all attributes, except “effectiveness of the
preventive measure,” were determined to be nonlinear and there-
fore recoded using effects codes.9,40 Based on model fit tests (AIC,
log-likelihood), the model most suitable for our data was selected
(see equation below), and how many classes could be identified
within the data (models ranging from 1 to 4 classes) was tested.
Vrtajc ¼ b0jc1b1jc type of disease physical disease rtajc1b2jc type of
disease mental disease rtajc1 b3jc type of disease physical disability rtajc
1 b4jc disease penetrance probability 30 out of 100 rtajc1b5jc disease
penetrance probability 80 of 100 rtajc1 b6jc preventive opportunity
operation rtajc1 b7jc preventive opportunity medication rtajc1 b8jc
preventive opportunity lifestyle changes rtajc1b9jc
effectiveness of preventive measure rtajc
Voptout ¼0
The systematic utility component (V) describes the observable
utility that respondent ® belonging to class (c) reported for
alternative (a)a in choice task (t)t. b0 represents the alternative
specific constant for receiving secondary findings from a genetic
test with 0% effectiveness and the average utility level for all other
attributes, and b1 to b9 are the attribute-level estimates. Interac-
tion terms between the attributes were not included, as they were
identified to be insignificant, confirming the outcomes of the focus
groups with the target population.
Importance weights for the attributes relative to the most
important attribute were calculated based on the results of the
LCMs, separately for all classes. The class-adjusted relative
importance was calculated by computing the relative importance
score of all attributes in each class separately as described above,
after which they were weighted according to class assignment
probability.
Choice consistency
To test whether differences between the TTT and NTTT were
attributable to any significant differences in the scale parameter
(ie, if choice consistency between respondents is significantly
higher in one sample compared with the other), a heteroscedastic
MNL (HMNL) model was estimated on the pooled data set.1,41
Participation probabilities
Separately for the TTT and NTTT samples, the probability that
individuals are willing to receive secondary finding from a genetic
test was estimated for different realistic implementation sce-
narios. Interclass correlations were estimated to measure the level
of agreement between the probabilities of every estimated
implementation scenario.Results
Sample Description
Within the NTTT sample, 391 of the 650 questionnaires (60%)
were returned. After removing respondents with .10% missing
answers on their choice task, 346 of these questionnaires (88%)
were used in the analysis. Within the TTT sample, initially, 381 of
the 650 questionnaires (59%) were returned. Of these, 287 (75%)
also returned their questionnaire after the TTT period, indicating
94 respondents (25%) dropped out. After removing respondents
with .10% missing answers on their choice task, 267 of these
questionnaires (93%) were used in the analysis.
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sample (Table 2), nor did they differ between the respondents who
completed the TTT-DCE and those who dropped out or between
respondents who completed the different blocks of the DCE.
Of the respondents who completed the TTT-DCE, 92% indicated
they had used the TTT period to think about the choices they were
offered and the information they had received (Table 2). Most
(72%) indicated they read the information they received again, 24%
of the respondents reported that they discussed the matter with
their family, and 15% indicated they did something else (which in
most cases was described as self-reflection/deliberation).
Choice Certainty
Within both samples, respondents reported a high mean cer-
tainty score (5.5 of 7 [SD 1.0]), which did not (significantly) differ
between samples. The proportion of respondents who indicated
they were very certain about their choice was also equal in both
samples (34%).
Dominant Decision-Making Behavior
In the TTT and NTTT sample, a relatively small proportion of
the respondents showed dominant decision-making behavior (ie,
lexicographic preferences) for choosing the opt-out (2% and 1%,
respectively) and for choosing the alternative with the highest
disease penetrance probability (1% and 2%, respectively). No
lexicographic preferences were found for the effectiveness of the
preventive measure attribute. The mean number of times the opt-
out was chosen (TTT 2.1 [SD 3.6]; NTTT 1.6 [SD 3.0]) and the mean
number of times the alternative with the highest disease pene-
trance probability was chosen (TTT 5.8 [SD 2.7]; NTTT 5.2 [SD 2.7])Table 2. Demographics and TTT-period activities stratified by
sample
TTT NTTT
Mean (SD) age, y 58.8 (4.5) 58.8 (4.3)
Gender
Male 39% 43%
Female 61% 57%
Educational level
Primary school 8% 11%
High school 31% 30%
University or higher education 61% 59%
Mean health literacy score (SD)* 3.8 (0.6) 3.8 (0.7)
Mean health numeracy score (SD) 4.7 (0.91) 4.6 (1.02)
General health status
Poor 2% 2%
Average 21% 15%
Good 77% 84%
Proportion of respondents who
reported they used the TTT period
92% N/A
Activities undertaken
Read the information over 72% N/A
Searched on internet 6% N/A
Discussed with family 24% N/A
Discussed with friends 9% N/A
Other 15% N/A
TTT indicates time to think.
*Problematic health literacy for mean scores between 1.8 and 2.4, inadequate
health literacy for mean scores between 0 and 1.6 points.36,37were significantly higher in the TTT sample as compared with the
NTTT sample.
Attribute-Level Interpretation
In both the TTT and NTTT sample, the dummy variable indi-
cating the highest level for disease penetrance probability was
shown to be statistically significant (TTT b = 2.55; P = , .01, NTTT
b = 2.45; P , .01), indicating respondents valued the part-worth
utilities between the levels nonlinearly. Given the levels of this
attribute, this shows that even though the distance between 30
and 80 is about twice as large as the difference between 5 and 30,
the impact of moving from 30 to 80 on utility is smaller compared
with moving from 5 to 30. The effectiveness of the preventive
measure attribute was considered to be valued as a continuous
attribute and therefore included as a linear variable in further
analyses (TTT b = 2.18; P = .03, NTTT b = .05; P = .48).
Attribute-Level Estimates and Relative Importance
In both the TTT and NTTT samples, a 3-class LCM turned out to
be the best-fitting model, indicating significant preference het-
erogeneity (Table 3). Classes are numbered according to class size,
with class 1 being the largest.
In both samples, the alternative specific constant in class 3 was
negative, indicating an a priori disutility for receiving secondary
findings from a genetic test with 0% effectiveness and the average
utility level for all other attributes, whereas the alternative specific
constant for the other 2 classes was positive (Table 3). In both
samples, the positive attribute-level estimate for effectiveness of
the preventive intervention indicated respondents prefer to
receive secondary findings from a genetic test if the effectiveness
of the available preventive measure increases.
A preference reversal was found when comparing class 2 of the
NTTT sample to the other classes in the NTTT as well as the TTT
sample. The most pronounced differences were found for the
disease penetrance probability attribute and the preventive op-
portunity attribute. Respondents in NTTT class 2 preferred to
receive secondary findings from a genetic test if the disease
penetrance probability decreases (as compared with increases)
and when there are no preventive opportunities available (as
compared with any of the availability preventive measures). The
probability of belonging to this class was 34%.
The effectiveness of the preventive measures attribute was
most important in both samples; however, the class-adjusted
relative importance scores differed between the TTT and NTTT
samples (Fig. 1).
Choice Consistency
The HMNL model showed a positive significant scale factor
when comparing the TTT and NTTT data files (P = .00). This in-
dicates that, as compared with the NTTT sample, respondents in
the TTT sample were more consistent when answering their
choice tasks.
Participation Probabilities
The participation probabilities were calculated for some real-
istic scenarios of returning secondary findings of a genetic test
(Table 4). Although the probabilities were relatively similar, the
mean utility and participation probability calculated based on the
TTT data were always lower as compared with those based on the
NTTT data. The interclass correlation coefficient—when comparing
the average class-adjusted participation probabilities between
both samples—was 0.97.
Table 3. Preferences for receiving secondary findings based on a panel latent class analysis separately for the TTT and NTTT sample.
TTT sample NTTT sample
Class 1 Class 2 Class 3 Class 1 Class 2 Class 3
Estimate SE Estimate SE Estimate SE Estimate SE Estimate SE Estimate SE
Constant 1.11‡ 0.27 1.88‡ 0.28 22.93‡ 0.27 2.98‡ 0.25 1.64‡ 0.38 21.97‡ 0.16
Type of disease
Life threatening (ref) 0.47‡ 0.10 1.24‡ 0.12 0.03 0.14 1.33‡ 0.09 0.28† 0.13 0.26† 0.11
Physical disease 20.09 0.10 -0.35‡ 0.11 20.09 0.15 20.39‡ 0.08 0.03 0.11 0.16 0.11
Mental disease 20.65‡ 0.12 20.12 0.10 0.06 0.14 20.39‡ 0.08 20.88‡ 0.15 20.23† 0.11
Physical disability 0.27† 0.10 20.77‡ 0.14 20.00 0.14 20.55‡ 0.10 0.57‡ 0.12 20.19* 0.10
Disease penetrance probability
5 out of 100 (ref) 20.54‡ 0.10 21.37‡ 0.10 20.61‡ 0.12 21.21‡ 0.09 0.55‡ 0.13 20.59‡ 0.09
30 out of 100 0.22‡ 0.07 0.08 0.08 20.03 0.12 0.17‡ 0.06 0.15* 0.08 20.16* 0.08
80 out of 100 0.32‡ 0.12 1.29‡ 0.12 0.64‡ 0.12 1.04‡ 0.12 20.70‡ 0.18 0.75‡ 0.09
Preventive opportunities
None (ref) 20.33‡ 0.11 21.69‡ 0.12 20.14 0.18 21.87‡ 0.10 0.38‡ 0.14 20.74‡ 0.11
Operation 20.07 0.12 0.62‡ 0.17 20.62‡ 0.23 0.57‡ 0.14 20.36† 0.15 20.13 0.13
Medication 20.17* 0.10 0.30‡ 0.10 0.02 0.17 0.58‡ 0.09 20.36‡ 0.14 0.11 0.11
Lifestyle changes 0.57‡ 0.11 0.77‡ 0.10 0.74‡ 0.15 0.72‡ 0.07 0.34† 0.14 0.76‡ 0.10
Effectiveness of the preventive measure 0.39‡ 0.04 0.18‡ 0.03 0.28‡ 0.04 0.20‡ 0.03 0.48‡ 0.08 0.25‡ 0.03
Mean class probability 0.43 0.38 0.19 0.44 0.34 0.22
Note. The attribute-level estimate of the reference categories can be calculated as 21 3 sum of the other attribute level estimates.
SE indicates standard error.
*P , .10.
†P , .05.
‡P , .01.
-- 5Conclusions and Discussion
This study aimed to empirically test whether and to what
extent the outcomes of a DCE differ when respondents are
allowed TTT about their choice options. Results showed that,
irrespective of whether respondents were offered TTT, they indi-
cated they were very certain about the choices that they made inFigure 1. Relative importance scores adjusted for class assignment s
samples.
0,00
1,00
0,90
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0,10
Type of the disease Disease penetrance
probabilitythe DCE. Nevertheless, the significant scale factor in the HMNL
model showed that respondents in the NTTT sample were signif-
icantly less consistent in their choices as compared with re-
spondents in the TTT sample, which is in line with previous
findings.22 In addition, respondents in the NTTT sample under-
valued the attribute related to disease penetrance probability,
which is the most abstract and complicated attribute in this DCE.eparately for the time to think (TTT) and no time to think (NTTT)
Preventive opportunities Effectiveness of 
preventive measure
Table 4. Utility and probability scores for receiving secondary findings given realistic implementation scenarios separate for the time to
think (TTT) and no time to think (NTTT) samples.
TTT NTTT
Class 1 Class 2 Class 3 Average Class 1 Class 2 Class 3 Average
Life-threatening disease for which an operation is possible
Scenario 1:
 Penetrance: 5 out of 100
 Effectiveness: 25%
Utility 1.95 2.82 23.43 1.26 4.17 3.31 21.81 2.56
Probability 0.87 0.94 0.03 0.74 0.98 0.96 0.14 0.79
Scenario 2:
 Penetrance: 80 out of 100
 Effectiveness: 25%
Utility 2.81 5.48 22.18 2.87 6.42 2.06 20.47 3.42
Probability 0.94 1.00 0.10 0.80 1.00 0.89 0.39 0.83
Scenario 3:
 Penetrance: 5 out of 100
 Effectiveness: 90%
Utility 4.22 1.68 21.13 2.24 3.03 7.17 20.79 3.60
Probability 0.99 0.84 0.24 0.79 0.95 1.00 0.31 0.83
Scenario 4:
 Penetrance: 80 out of 100
 Effectiveness: 90%
Utility 5.34 6.65 20.36 4.75 7.72 5.18 1.16 5.41
Probability 1.00 1.00 0.41 0.89 1.00 0.99 0.76 0.95
Physical disease for which lifestyle changes are possible
Scenario 5:
 Penetrance: 5 out of 100
 Effectiveness: 25%
Utility 2.03 1.38 22.19 0.98 2.60 3.76 21.02 2.20
Probability 0.88 0.80 0.10 0.70 0.93 0.98 0.27 0.80
Scenario 6:
 Penetrance: 80 out of 100
 Effectiveness: 25%
Utility 2.89 4.04 20.94 2.60 4.85 2.51 0.33 3.06
Probability 0.95 0.98 0.28 0.83 0.99 0.92 0.58 0.88
Scenario 7:
 Penetrance: 5 out of 100
 Effectiveness: 75%
Utility 3.98 2.28 20.79 2.43 3.60 6.16 0.24 3.73
Probability 0.98 0.91 0.31 0.83 0.97 1.00 0.56 0.89
Scenario 8:
 Penetrance: 80 out of 100
 Effectiveness: 75%
Utility 5.40 6.53 0.58 4.91 7.57 5.16 1.68 5.45
Probability 1.00 1.00 0.64 0.93 1.00 0.99 0.84 0.96
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undervalued it because they lacked understanding of the attribute
or because they did not give enough thought as to how the
penetrance probability would influence their decision. Such out-
comes were expected based on previous TTT studies20,22,23 and
previously conducted DCE studies in which respondents were not
offered any TTT.42,43 These effects have previously been related to
low health literacy or numeracy levels of respondents.43 Instead of
concluding that DCE studies might not be feasible to all subgroups
in a population, offering respondents TTT may partly resolve this
issue.
In addition, in the NTTT sample, preference reversals were
found in one of the classes. In this class, preference was given to
receiving information about a disease with low penetrance
probability (instead of a high probability) with no preventive
opportunities (instead of lifestyle changes, surgery, or medica-
tion). Outcomes in this class most likely represent a proportion of
respondents who did not understand or did not pay attention tothe choice question that was asked (class membership analysis
[results not shown] revealed that lower education and lower
literate respondents were more likely to belong to this class). They
might answer another choice question, namely, “What disease
would you prefer to be the outcome of a genetic test?” or “What
information would you be able to handle?” This “mistake” was
made by a relatively large proportion of the population, given that
the probability of belonging to this class in the LCM was 34%.
Preference reversals have been previously reported in DCE
studies.17,42,44 Although these divergent outcomes can be
explained, they do pose a threat to the validity of the DCE out-
comes as they biased the results. Because no reversals were found
in the TTT sample, offering respondents TTT might help to increase
attention to and understanding of the choice questions.
Applying a TTT approach resulted in a 25% dropout rate;
however, response (and dropout) was not selective. Future
research using this TTT approach should investigate to what
extent dropout rates in the TTT-DCEs are predictable. Based on the
-- 7outcomes of those studies, recommendations regarding over-
sampling in a TTT-DCE can be drafted to further increase the
validity of this approach. Oversampling seems a highly feasible
solution in the current research setting, because it will not greatly
affect the research budget, as most surveys use online tools.
Future research should also focus on the length of the TTT
period. This period should be balanced between allowing for
enough time to properly think about the topic but not too much
time that people forget important information or that the study
duration is significantly increased.10 The current study used a 7-
day TTT window, whereas previous interview-led TTT-DCE
studies showed similar results after a 1-day TTT window.20,22,23 In
addition, research should invest in studying probes that help
people to think about or search for additional information, so
respondents use the TTT period efficiently. Such research could
lead to establishing a framework that describes in which cases a
TTT is most helpful and how the TTT period can best be incor-
porated in a DCE. In addition, further research should explore the
actual impact of psychosocial factors (such as attitudes of friends
and family members but also personal emotional status) on de-
cision making to better understand to what extent a TTT period
captures these elements.
This study was subject to some limitations. First, the study was
conducted in a population consisting of healthy research partici-
pants aged 50 to 64 years who participated in an extensive health
checkup. Study results can therefore not be generalized to younger
or older populations. Especially in the older population, one might
expect a high benefit of TTT applications, because previous
research has shown that older individuals have more difficulty
with understanding complicated health information and making
ad hoc decisions in DCEs.45 Additional research should investigate
the advantage of this approach in the elderly population. Second,
as compared with the general population, people in the current
sample were used to making complicated decisions about their
health status because they agreed to be part of a research project.
Therefore, the effects of using a TTT approach in a DCE study
directed at the general population might be more pronounced
because they are less familiar with making complex health-related
decisions. Third, although the response rate was better than what
one can expect for surveys, the response might still be selective.
As compared with the average Swedish population, respondents
to this study were slightly higher educated. Although higher
educated respondents might be more skilled to find and process
additional information, the effects of a TTT approach are expected
to be even more pronounced among lower educated individuals
because the TTT period offers them a larger time window (as
compared with standard online surveys) to think about their op-
tions and to find additional information or to discuss with peers..
In summary, current findings might underestimate the true value
of a TTT approach in DCE studies.
In conclusion, offering respondents TTT in a DCE influences
decision making and preferences. Developers of future DCEs
regarding complex health-related decisions are advised to
consider this TTT approach (ie, mimicking real-life decision mak-
ing) to enhance the validity of the elicited preferences.Acknowledgments
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